{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:19:53Z","timestamp":1765887593166},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.steroids.2014.03.008","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T17:21:26Z","timestamp":1396027286000},"page":"57-63","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Adrenocortical function in hypotensive patients with end stage renal disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Alejandro L.","family":"Arregger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela M.L.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Zucchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira C.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Elbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana N.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.03.008_b0005","first-page":"331","article-title":"Chronic hypotension in the dialysis patient","volume":"15","author":"Cases","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.steroids.2014.03.008_b0010","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/13.12.3024","article-title":"Dialysis hypotension: do we see light at the end of the tunnel?","volume":"13","author":"Passauer","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.steroids.2014.03.008_b0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1523-1755.2000.00888.x","article-title":"Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension","volume":"57","author":"Cases","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.steroids.2014.03.008_b0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1525-139X.2011.00915.x","article-title":"Why are some dialysis patients chronically hypotensive in the absence of heart disease and volume depletion?","volume":"24","author":"Palmer","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.steroids.2014.03.008_b0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0960-0760(93)90142-J","article-title":"The role of vascular steroid receptors in the control of vascular contractility and peripheral vascular resistance","volume":"45","author":"Kornel","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2014.03.008_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(98)00230-2","article-title":"The role of corticosteroids in the regulation of vascular tone","volume":"41","author":"Ulliam","year":"1999","journal-title":"Cardiovas Res"},{"key":"10.1016\/j.steroids.2014.03.008_b0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1440-1681.1998.tb02349.x","article-title":"The nitric oxide system and cortisol induced hypertension in humans","volume":"25","author":"Kelly","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.steroids.2014.03.008_b0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.RES.84.2.193","article-title":"Glucocorticoids down-regulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium","volume":"84","author":"Jun","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2014.03.008_b0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/endo-119-2-661","article-title":"Inhibition by hydrocortisone of prostacyclin synthesis by rat aorta and its reversal with RU486","volume":"119","author":"Jeremy","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.03.008_b0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mce.2003.10.047","article-title":"Aldosterone target organ protection by eplerenone","volume":"217","author":"Rudolph","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.03.008_b0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1152\/ajpendo.1990.258.4.E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"G\u00f3mez-S\u00e1nchez","year":"1990","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.03.008_b0060","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1152\/ajpendo.2001.281.6.E1122","article-title":"Non-traditional aspects of aldosterone physiology","volume":"281","author":"Ngarmukos","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.03.008_b0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000180516","article-title":"Kidney and adrenocortical hormones","volume":"15","author":"Kleeman","year":"1975","journal-title":"Nephron"},{"key":"10.1016\/j.steroids.2014.03.008_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0272-6386(87)80161-0","article-title":"Abnormalities in the hypothalamic\u2013pituitary\u2013adrenocortical axis in patients with chronic renal failure","volume":"9","author":"Luger","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.steroids.2014.03.008_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000045132","article-title":"Paper chromatography prior to cortisol RIA allows for accurate use of the dexamethasone suppression test in chronic renal failure","volume":"80","author":"Van Herle","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.steroids.2014.03.008_b0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000183237","article-title":"Cortisol binding in uremic plasma. I. Absence of abnormal cortisol binding to cortisol binding to corticosteroid-binding globulin","volume":"37","author":"Rosman","year":"1984","journal-title":"Nephron"},{"key":"10.1016\/j.steroids.2014.03.008_b0085","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1046\/j.1523-1755.2002.00308.x","article-title":"Increased cortisol metabolites and reduced activity of 11\u03b2-hydroxysteroid dehydrogenase in patients on hemodialysis","volume":"61","author":"N\u2019Gankam","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.steroids.2014.03.008_b0090","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1056\/NEJM197405302902213","article-title":"Adrenal responsiveness in chronic hemodialysis (letter to Editor)","volume":"290","author":"Barbour","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.03.008_b0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1210\/jcem-48-1-92","article-title":"Adrenocorticotropin-cortisol axis abnormalities in hemodialysis patients","volume":"48","author":"McDonald","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.03.008_b0100","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/archinte.1982.00340210040010","article-title":"Evaluation of the hypothalamic\u2013hypophyseal\u2013adrenal axis in patients receiving long-term hemodialysis","volume":"42","author":"Ramirez","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.steroids.2014.03.008_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08860228309076049","article-title":"Adrenal responsiveness during and after intermittent hemodialysis","volume":"7","author":"Grekas","year":"1983","journal-title":"Clin Exp Dial Apheresis"},{"key":"10.1016\/j.steroids.2014.03.008_b0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/08860229509037629","article-title":"The impact of long-term hemodialysis on pituitary\u2013adrenocortical function","volume":"17","author":"Vigna","year":"1995","journal-title":"Ren Fail"},{"key":"10.1016\/j.steroids.2014.03.008_b0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/ajkd.1998.v32.pm9669424","article-title":"Adrenal function in patients with chronic renal failure","volume":"32","author":"Clodi","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.steroids.2014.03.008_b0120","first-page":"4","article-title":"Adrenocortical insufficiency in renal amyloidosis","volume":"62","author":"Gmar-Bouraoui","year":"2001","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.steroids.2014.03.008_b0125","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/10.7.1237","article-title":"Occult adrenal insufficiency secondary to amyloidosis in the context of chronic renal failure","volume":"10","author":"Harvey","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.steroids.2014.03.008_b0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.ten.0000194248.85361.bf","article-title":"Salivary steroids in response to ACTH: a less invasive approach to assess adrenal function in hypotensive patients with chronic renal failure","volume":"16","author":"Contreras","year":"2006","journal-title":"The Endocrinologist"},{"key":"10.1016\/j.steroids.2014.03.008_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.steroids.2007.09.001","article-title":"Diagnostic value of salivary cortisol in end stage renal disease","volume":"73","author":"Arregger","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.03.008_b0140","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.03.008_b0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2265.2004.02144.x","article-title":"A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin","volume":"61","author":"Contreras","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.steroids.2014.03.008_b0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004872-200402000-00023","article-title":"Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism","volume":"22","author":"Ferrari","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.steroids.2014.03.008_b0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1902\/jop.1980.51.6.336","article-title":"Scopp IW Salivary composition and calculus formation in patients undergoing hemodialysis","volume":"51","author":"Epstein","year":"1980","journal-title":"J Periodontol"},{"key":"10.1016\/j.steroids.2014.03.008_b0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0030-4220(69)90359-4","article-title":"Masive neck swelling secondary to uremic submaxillary gland involvement","volume":"27","author":"Rothstein","year":"1969","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.steroids.2014.03.008_b0165","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1053\/ajkd.2000.19810","article-title":"Decreased Salivary function in patients with end stage renal disease requiring hemodialysis","volume":"36","author":"Kao","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.steroids.2014.03.008_b0170","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","article-title":"Adrenal insufficiency","volume":"361","author":"Arlt","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.steroids.2014.03.008_b0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0039-6060(97)90280-4","article-title":"A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency","volume":"121","author":"Glowniak","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.steroids.2014.03.008_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00007890-198308000-00006","article-title":"The use of a cosyntropin stimulation test to predict adrenal suppression in renal transplant patients being withdrawn from prednisone","volume":"36","author":"Canafax","year":"1983","journal-title":"Transplantation"},{"key":"10.1016\/j.steroids.2014.03.008_b0185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","article-title":"Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications","volume":"37","author":"Epstein","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.steroids.2014.03.008_b0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1980.11","article-title":"Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency","volume":"17","author":"Schambelan","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.steroids.2014.03.008_b0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ndt\/12.2.321","article-title":"Vasoactive hormones in uraemic patients with chronic hypotension","volume":"12","author":"Armengol","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.steroids.2014.03.008_b0200","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/ki.1989.248","article-title":"Reduced angiotensin receptors and pressure responses in hypotensive hemodialysis patients","volume":"36","author":"Moore","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.steroids.2014.03.008_b0205","first-page":"288","volume":"26","author":"S\u00f8rensen","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.steroids.2014.03.008_b0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.2002.tb04413.x","article-title":"Primary aldosteronism: management issues","volume":"970","author":"Young","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.steroids.2014.03.008_b0215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0030-1248287","article-title":"Salivary aldosterone as a diagnostic aid in primary aldosteronism","volume":"42","author":"Manolopoulou","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.steroids.2014.03.008_b0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/EC-12-0058","article-title":"Circadian rhythm of salivary cortisol, plasma cortisol and plasma ACTH in end-stage renal disease","volume":"2","author":"Raff","year":"2013","journal-title":"Endocrin Connect"},{"key":"10.1016\/j.steroids.2014.03.008_b0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/jcem-50-1-46","article-title":"Pituitary\u2013adrenocortical function in chronic renal failure: studies of episodic secretion of cortisol and dexamethasone suppressibility","volume":"50","author":"Wallace","year":"1980","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:13:14Z","timestamp":1565298794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":45,"alternative-id":["S0039128X14000622"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.03.008","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenocortical function in hypotensive patients with end stage renal disease","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}